• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 型:对其结构复杂性和功能方面的深入了解,有助于药物和疫苗的研发。

SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development.

机构信息

Department of Biophysics, Panjab University, Chandigarh 160014, India.

Department of Biophysics, Panjab University, Chandigarh 160014, India; UIPS, Panjab University, Chandigarh 160014, India.

出版信息

Int J Biol Macromol. 2021 May 15;179:45-60. doi: 10.1016/j.ijbiomac.2021.02.212. Epub 2021 Mar 1.

DOI:10.1016/j.ijbiomac.2021.02.212
PMID:33662418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7919520/
Abstract

Globally, SARS-CoV-2 has emerged as threat to life and economy. Researchers are trying to find a cure against this pathogen but without much success. Several attempts have been made to understand the atomic level details of SARS-CoV-2 in the past few months. However, one review with all structural details for drug and vaccine development has been missing. Hence, this review aims to summarize key functional roles played by various domains of SARS-CoV-2 genome during its entry into the host, replication, repression of host immune response and overall viral life cycle. Additionally, various proteins of SARS-CoV-2 for finding a potent inhibitor have also been highlighted. To mitigate this deadly virus, an understanding of atomic level information, pathogenicity mechanisms and functions of different proteins in causing the infection is imperative. Thus, these structural details would finally pave the way for development of a potential drug/vaccine against the disease caused by SARS-CoV-2.

摘要

从全球范围来看,SARS-CoV-2 已经对生命和经济构成威胁。研究人员正试图寻找针对这种病原体的治疗方法,但收效甚微。在过去的几个月里,人们已经做出了几次尝试来了解 SARS-CoV-2 的原子水平细节。然而,目前还缺少一份涵盖所有结构细节的关于药物和疫苗开发的综述。因此,本综述旨在总结 SARS-CoV-2 基因组的各个结构域在进入宿主、复制、抑制宿主免疫反应和整个病毒生命周期中所扮演的关键功能角色。此外,还强调了 SARS-CoV-2 的各种蛋白在寻找有效的抑制剂方面的作用。为了减轻这种致命病毒的危害,了解原子水平信息、不同蛋白在致病过程中的发病机制和功能至关重要。因此,这些结构细节最终将为开发针对 SARS-CoV-2 引起的疾病的潜在药物/疫苗铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/5d8517b4f815/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/f52dfa08af22/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/672f619be46b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/6f7579c8dc09/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/56f0caa24a7a/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/873451185583/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/0002ada31fdb/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/e6adb0878a96/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/5d8517b4f815/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/f52dfa08af22/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/672f619be46b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/6f7579c8dc09/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/56f0caa24a7a/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/873451185583/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/0002ada31fdb/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/e6adb0878a96/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0c/7919520/5d8517b4f815/gr8_lrg.jpg

相似文献

1
SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development.严重急性呼吸综合征冠状病毒 2 型:对其结构复杂性和功能方面的深入了解,有助于药物和疫苗的研发。
Int J Biol Macromol. 2021 May 15;179:45-60. doi: 10.1016/j.ijbiomac.2021.02.212. Epub 2021 Mar 1.
2
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.SARS-CoV-2 的结构蛋白和非结构蛋白及其在 COVID-19 中的治疗靶点的作用。
Cells. 2021 Apr 6;10(4):821. doi: 10.3390/cells10040821.
3
Structure of Nonstructural Protein 1 from SARS-CoV-2.SARS-CoV-2 的非结构蛋白 1 结构。
J Virol. 2021 Jan 28;95(4). doi: 10.1128/JVI.02019-20.
4
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
5
Structural biology of SARS-CoV-2 and implications for therapeutic development.SARS-CoV-2 的结构生物学与治疗开发的意义。
Nat Rev Microbiol. 2021 Nov;19(11):685-700. doi: 10.1038/s41579-021-00630-8. Epub 2021 Sep 17.
6
Insights into the Structural Complexities of SARS-CoV-2 for Therapeutic and Vaccine Development.深入了解 SARS-CoV-2 的结构复杂性,以促进治疗和疫苗的研发。
Comb Chem High Throughput Screen. 2023;26(11):1945-1959. doi: 10.2174/1386207326666221108095705.
7
The structural basis of accelerated host cell entry by SARS-CoV-2†.SARS-CoV-2 加速宿主细胞进入的结构基础。
FEBS J. 2021 Sep;288(17):5010-5020. doi: 10.1111/febs.15651. Epub 2020 Dec 14.
8
Structural insights into SARS-CoV-2 proteins.SARS-CoV-2 蛋白的结构见解。
J Mol Biol. 2021 Jan 22;433(2):166725. doi: 10.1016/j.jmb.2020.11.024. Epub 2020 Nov 24.
9
From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses.从 SARS 到 SARS-CoV-2,了解大流行人类冠状病毒的结构、致病性和免疫方面的见解。
Infect Genet Evol. 2020 Nov;85:104502. doi: 10.1016/j.meegid.2020.104502. Epub 2020 Aug 13.
10
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.

引用本文的文献

1
Progressive Evolutionary Dynamics of Gene-Specific ω Led to the Emergence of Novel SARS-CoV-2 Strains Having Super-Infectivity and Virulence with Vaccine Neutralization.基因特异性ω的渐进进化动力学导致具有超级感染力和毒力的新型 SARS-CoV-2 菌株的出现,这些菌株具有疫苗中和作用。
Int J Mol Sci. 2024 Jun 7;25(12):6306. doi: 10.3390/ijms25126306.
2
FEOpti-ACVP: identification of novel anti-coronavirus peptide sequences based on feature engineering and optimization.FEOpti-ACVP:基于特征工程和优化的新型抗冠状病毒肽序列的鉴定。
Brief Bioinform. 2024 Jan 22;25(2). doi: 10.1093/bib/bbae037.
3
Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.

本文引用的文献

1
Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein.严重急性呼吸综合征冠状病毒2核衣壳蛋白C末端结构域的结构表征
Mol Biomed. 2020;1(1):2. doi: 10.1186/s43556-020-00001-4. Epub 2020 Aug 6.
2
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*.一种快速获得多种高活性 SARS-CoV-2 主蛋白酶抑制剂的方法*。
ChemMedChem. 2021 Mar 18;16(6):942-948. doi: 10.1002/cmdc.202000924. Epub 2020 Dec 10.
3
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
在 COVID-19 中,抗 NP、抗 RBD 和抗 Spike 抗体的独特特征可区分死亡和存活。
Front Immunol. 2023 Oct 9;14:1206979. doi: 10.3389/fimmu.2023.1206979. eCollection 2023.
4
Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review.新冠病毒大流行后毛霉病的毒力特征和新型药物输送策略:全面综述。
Front Immunol. 2023 Sep 25;14:1264502. doi: 10.3389/fimmu.2023.1264502. eCollection 2023.
5
Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.SARS-CoV-2 引发的神经系统表现:复杂性、机制与相关紊乱。
Eur J Med Res. 2023 Aug 30;28(1):307. doi: 10.1186/s40001-023-01293-2.
6
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees.使用BNT162b2进行异源加强免疫可在接种科兴疫苗的人群中诱导产生高特异性抗体水平。
Vaccines (Basel). 2023 Jun 30;11(7):1183. doi: 10.3390/vaccines11071183.
7
Insights into the SARS-CoV-2 ORF6 Mechanism of Action.深入了解 SARS-CoV-2 ORF6 的作用机制。
Int J Mol Sci. 2023 Jul 18;24(14):11589. doi: 10.3390/ijms241411589.
8
Identification of G-quadruplex DNA sequences in SARS-CoV2.鉴定 SARS-CoV2 中的 G-四链体 DNA 序列。
Immunogenetics. 2022 Oct;74(5):455-463. doi: 10.1007/s00251-022-01257-6. Epub 2022 Mar 18.
9
Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.COVID-19危机中的毛霉病:发病机制、诊断及对抗传播的新型治疗策略
Front Microbiol. 2022 Jan 4;12:794176. doi: 10.3389/fmicb.2021.794176. eCollection 2021.
10
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets.通过多靶点鉴定具有抗SARS-CoV-2能力的化合物的药物再利用
Pharmaceutics. 2022 Jan 12;14(1):176. doi: 10.3390/pharmaceutics14010176.
SARS-CoV-2 的非结构蛋白 1 是一种强大的致病性因子,它将宿主蛋白合成机制引导到病毒 RNA 上。
Mol Cell. 2020 Dec 17;80(6):1055-1066.e6. doi: 10.1016/j.molcel.2020.10.034. Epub 2020 Oct 29.
4
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.针对重组 SARS-CoV-2 刺突蛋白的位点特异性 N-糖基化分析。
Mol Cell Proteomics. 2021;20:100058. doi: 10.1074/mcp.RA120.002295. Epub 2021 Feb 11.
5
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.抑制剂结合的 SARS-CoV-2 木瓜蛋白酶样蛋白酶的活性分析和晶体结构:抗 COVID-19 药物设计的框架。
Sci Adv. 2020 Oct 16;6(42). doi: 10.1126/sciadv.abd4596. Print 2020 Oct.
6
Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2.严重急性呼吸综合征冠状病毒 2 非结构蛋白 10 的晶体结构
Int J Mol Sci. 2020 Oct 6;21(19):7375. doi: 10.3390/ijms21197375.
7
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.SARS-CoV-2 ORF3b 是一种有效的干扰素拮抗剂,其活性可被一种自然发生的延长变异体增强。
Cell Rep. 2020 Sep 22;32(12):108185. doi: 10.1016/j.celrep.2020.108185. Epub 2020 Sep 4.
8
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.猫冠状病毒药物可抑制新型冠状病毒的主要蛋白酶并阻断病毒复制。
Nat Commun. 2020 Aug 27;11(1):4282. doi: 10.1038/s41467-020-18096-2.
9
An updated min-review on environmental route of the SARS-CoV-2 transmission.关于 SARS-CoV-2 经环境传播途径的最新简要综述。
Ecotoxicol Environ Saf. 2020 Oct 1;202:111015. doi: 10.1016/j.ecoenv.2020.111015. Epub 2020 Jul 9.
10
Variant analysis of SARS-CoV-2 genomes.SARS-CoV-2 基因组变异分析。
Bull World Health Organ. 2020 Jul 1;98(7):495-504. doi: 10.2471/BLT.20.253591. Epub 2020 Jun 2.